Early Detection Research Network

AP1S2

Aliases:
This biomarker is also known as:
  • MRXSF,
  • clathrin assembly protein complex 1 sigma-1B small chain,
  • Sigma1B-adaptin,
  • Golgi adaptor HA1/AP1 adaptin sigma-1B subunit,
  • Adapter-related protein complex 1 sigma-1B subunit,
  • SIGMA1B,
  • adaptor protein complex AP-1 sigma-1B subunit,
  • golgi adaptor HA1/AP1 adaptin sigma 1B subunit,
  • golgi adaptor HA1/AP1 adaptin sigma-1B subunit,
  • MGC:1902,
  • sigma1B-adaptin,
  • sigma 1B subunit of AP-1 clathrin,
  • adaptor-related protein complex 1, sigma 2 subunit,
  • Clathrin assembly protein complex 1 sigma-1B small chain,
  • Sigma-adaptin 1B,
  • AP-1 complex subunit sigma-2,
  • Adaptor protein complex AP-1 sigma-1B subunit,
  • adapter-related protein complex 1 sigma-1B subunit,
  • Sigma 1B subunit of AP-1 clathrin,
  • mental retardation, X-linked 59,
  • sigma-adaptin 1B,
  • AP1S2,
  • clathrin adaptor complex AP1 sigma 1B subunit,
  • MRX59,
  • MRXS21,

Description…

adaptor-related protein complex 1, sigma 2 subunit

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Under Review
Type: Gene
HGNC Name: AP1S2

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact the Informatics Center if you should have access to this biomarker.